Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Green

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 11, 2017
Randomised trial of a parent-mediated intervention for infants at high risk for autism: longitudinal outcomes to age 3 yearsJonathan Green, Andrew Pickles, Greg Pasco, et al.
Cell Reports|May 25, 2022
Stromal AR inhibits prostate tumor progression by restraining secretory luminal epithelial cellsYueli Liu, Jiawen Wang, Corrigan Horton, et al.
Bone|January 31, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitroBeiqing Pan, Luen Bik To, Amanda N Farrugia, et al.
Developmental Medicine and Child Neurology|August 21, 2020
Autism in neurofibromatosis type 1: misuse of covariance to dismiss autistic trait burdenStephanie M Morris, Maria T Acosta, Shruti Garg, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 7, 2003
Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survivalPeter I Croucher, Raeve De Hendrik, Mark J Perry, et al.
Frontiers in Public Health|February 16, 2024
Locked down-locked in: experiences of families of young children with autism spectrum disorders in Delhi, IndiaAbhipreet Kaur, Gitanjali Lall, Minal Abhilashi, et al.
Trials|October 12, 2023
A randomised controlled trial of clinical and cost-effectiveness of the PASS Plus intervention for young children with autism spectrum disorder in New Delhi, India: study protocol for the COMPASS trialReetabrata Roy, Kathy Leadbitter, Gemma Shields, et al.
International Review of Psychiatry (Abingdon, England)|June 25, 2015
Parents' perspectives on care of children with autistic spectrum disorder in South Asia - Views from Pakistan and IndiaAyesha Minhas, Vivek Vajaratkar, Gauri Divan, et al.
Cerebral Cortex Communications|June 8, 2022
Neuroanatomical correlates of working memory performance in Neurofibromatosis 1Cameron Sawyer, Jonathan Green, Ben Lim, et al.
Molecular Autism|October 15, 2024
Developmental trajectories in infants and pre-school children with Neurofibromatosis 1Hannah Slevin, Fiona Kehinde, Jannath Begum-Ali, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 11, 2017
Randomised trial of a parent-mediated intervention for infants at high risk for autism: longitudinal outcomes to age 3 yearsJonathan Green, Andrew Pickles, Greg Pasco, et al.
Cell Reports|May 25, 2022
Stromal AR inhibits prostate tumor progression by restraining secretory luminal epithelial cellsYueli Liu, Jiawen Wang, Corrigan Horton, et al.
Bone|January 31, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitroBeiqing Pan, Luen Bik To, Amanda N Farrugia, et al.
Developmental Medicine and Child Neurology|August 21, 2020
Autism in neurofibromatosis type 1: misuse of covariance to dismiss autistic trait burdenStephanie M Morris, Maria T Acosta, Shruti Garg, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 7, 2003
Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survivalPeter I Croucher, Raeve De Hendrik, Mark J Perry, et al.
Frontiers in Public Health|February 16, 2024
Locked down-locked in: experiences of families of young children with autism spectrum disorders in Delhi, IndiaAbhipreet Kaur, Gitanjali Lall, Minal Abhilashi, et al.
Trials|October 12, 2023
A randomised controlled trial of clinical and cost-effectiveness of the PASS Plus intervention for young children with autism spectrum disorder in New Delhi, India: study protocol for the COMPASS trialReetabrata Roy, Kathy Leadbitter, Gemma Shields, et al.
International Review of Psychiatry (Abingdon, England)|June 25, 2015
Parents' perspectives on care of children with autistic spectrum disorder in South Asia - Views from Pakistan and IndiaAyesha Minhas, Vivek Vajaratkar, Gauri Divan, et al.
Cerebral Cortex Communications|June 8, 2022
Neuroanatomical correlates of working memory performance in Neurofibromatosis 1Cameron Sawyer, Jonathan Green, Ben Lim, et al.
Molecular Autism|October 15, 2024
Developmental trajectories in infants and pre-school children with Neurofibromatosis 1Hannah Slevin, Fiona Kehinde, Jannath Begum-Ali, et al.
Pageof 27